Malignant non-dysgerminomatous germ cell tumor of ovary

Malignant non-dysgerminomatous germ cell tumors of the ovary are a group of rare, aggressive ovarian cancers that arise from primordial germ cells. This category encompasses several histological subtypes including yolk sac tumor (endodermal sinus tumor), immature teratoma, embryonal carcinoma, choriocarcinoma, and mixed germ cell tumors. These tumors are distinct from dysgerminomas and tend to occur predominantly in children, adolescents, and young women, typically during the reproductive years. These tumors primarily affect the ovary but can spread to other structures within the pelvis and abdomen, and may metastasize to the lungs, liver, and lymph nodes. Key symptoms include abdominal or pelvic pain, abdominal distension or a palpable mass, and in some cases menstrual irregularities or precocious puberty in younger patients. Certain subtypes produce specific tumor markers: yolk sac tumors secrete alpha-fetoprotein (AFP), while choriocarcinomas produce human chorionic gonadotropin (hCG). Elevated levels of these markers aid in diagnosis and monitoring of treatment response. The current treatment approach typically involves surgical resection, often with fertility-sparing surgery (unilateral salpingo-oophorectomy) given the young age of most patients, followed by platinum-based combination chemotherapy, most commonly the BEP regimen (bleomycin, etoposide, and cisplatin). With modern treatment protocols, the prognosis has improved significantly, with high cure rates even in advanced-stage disease. Regular monitoring of serum tumor markers and imaging is essential for detecting recurrence. Prognosis varies by histological subtype and stage at diagnosis, but overall survival rates are favorable with appropriate multimodal therapy.

Common questions about Malignant non-dysgerminomatous germ cell tumor of ovary